adagrasib
mirati
['sclc', 'krystal-1', 'mrtx849', 'adagrasib', 'nsclc', 'krystal,1']
#asco22 dr. presents data on adagrasib (mrtx849) in patients with #kras g12c nsclc and active, untreated cns metastases in krystal-1. about 27-42% have brain metastases - important need. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him